Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Chemistry and Laboratory Medicine|December 25, 2019
Mixing studies for lupus anticoagulant: mostly yes, sometimes noEmmanuel FavaloroClinical Chemistry and Laboratory Medicine|May 15, 2020
COVID-19: progression of disease and intravascular coagulation - present status and future perspectivesJob Harenberg, Emmanuel FavaloroPathology|November 1, 2019
Coagulation studies: achieving the right mix in a large laboratory networkRichard Blennerhassett, Emmanuel Favaloro, Leonardo PasalicAmerican Journal of Clinical Pathology|February 12, 2022
An Analysis of the Sensitivity of the Activated Partial Thromboplastin Time (APTT) Assay, as Used in a Large Laboratory Network, to Coagulation Factor DeficienciesLouis Do, Emmanuel Favaloro, Leonardo PasalicAmerican Journal of Clinical Pathology|April 22, 2005
External quality assurance of DNA testing for thrombophilia mutationsMark Hertzberg, Sue Neville, Emmanuel Favaloro, et al.Acta Bio-Medica : Atenei Parmensis|May 12, 2022
Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19Brandon Henry, Stefanie Benoit, Jens Vikse, et al.Acta Bio-Medica : Atenei Parmensis|March 22, 2022
Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19Brandon Michael Henry, Stefanie Benoit, Jens Vikse, et al.Pathology|December 21, 2011
Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAPRoslyn Bonar, Emmanuel Favaloro, Diane Zebeljan, et al.Pathology|July 1, 2014
Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venomLisa F Lincz, Fiona E Scorgie, Christopher I Johnston, et al.Pathology|June 19, 2004
A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assaysRichard Wong, Emmanuel Favaloro, Wendy Pollock, et al.Pageof 2